Uncategorized
Featured Stories
DaVita Inc. 1st Quarter 2026 Results
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
CMS Proposed Rule Would Reduce Medicare ESRD Reimbursement
DaVita Inc. (NYSE: DVA). The Centers for Medicare and Medicaid Services (CMS) has published a proposed rule containing its 2006 Physician Fee Schedule. Included in this proposed rule are revisions…
-
DaVita Inc. Commences Exchange Offer
DaVita Inc. announced today that it has commenced an offer to exchange (the “Exchange Offer”) up to $500,000,000 of its 6-5/8% Senior Notes due 2013, registered under the Securities Act of 1933,…
-
DaVita Announces Signing of Definitive Agreement With RenalAmerica
DaVita Inc. , announced today that DaVita and Gambro Healthcare, Inc. have entered into a definitive agreement with RenalAmerica, Inc. to sell 70 freestanding renal dialysis centers to…
-
DaVita Inc. Reports 2nd Quarter 2005 Results
DaVita Inc. , today announced results for the quarter ended June 30, 2005. Net income for the three months and six months ended June 30, 2005 was $52.9 million and $109.3 million, or $0.51 and…
-
Medicare to Award Contract for Demonstration Project to Improve Care for Beneficiaries With High Medical Costs to RMS Disease Management, LLC
DaVita Inc. announced that The Centers for Medicare & Medicaid Services (CMS) has selected RMS Disease Management, LLC, a wholly-owned subsidiary of DaVita, to operate a three-year demonstration…